Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Clinical Study to Determine the Safety and Efficacy of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area

NCT05226143 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer Inc. (J&JCI) as lead sponsor.

NCT NCT05226143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Clinical Study to Determine the Safety and Efficacy of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
Lead sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Phase
Not applicable
Overall status
Completed
Start date
February 21, 2022
Completion date
March 9, 2022
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic